Fairvalue-Calculator Fairvalue-Calculator
EN DE

M.I.TECH Co (179290) Fair Value & Analysis

Healthcare · KR · Market cap 163B KRW

Price4,255 KRW
Fair Value7,004 KRW
Upside+64.6%
Quality95/100
Evidence: High Range 5,253 KRW – 11,981 KRW

Fair value as of: Jun 24, 2026

Analysis

M.I.TECH Co (179290) currently trades at 4,255 KRW, while our model-based Fair Value estimate is 7,004 KRW — implying the stock looks roughly 64.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment. The company was formerly known as Solco Intermed Co., Ltd. and changed its name to M.I.TECH Co.,Ltd in March 1999. M.I.TECH Co.,Ltd was founded in 1991 and is headquartered in Pyeongtaek-Si, South Korea. M.I.TECH Co.,Ltd operates as a subsidiary of Synergy Innovation Co., Ltd.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is M.I.TECH Co (179290) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 7,004 KRW versus a price of 4,255 KRW — about +65% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 179290?
Our 21-model fair value for M.I.TECH Co is 7,004 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 4,255 KRW.
What is the quality score of 179290?
M.I.TECH Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.